Genetically modified T-lymphocyte
RxNorm 2051658
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2051658 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Genetically modified T-lymphocyte.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Genetically modified T-cell
(Atom ID: 10299137)
FN
Full form of descriptor (FN):
Genetically modified T-cell (substance)
(Atom ID: 10299138)
PT
Designated preferred name (PT):
Genetically modified T-cell-containing product
(Atom ID: 12536826)
SY
Synonym (SY):
Genetically modified T-lymphocyte
(Atom ID: 10299140)
FN